1. Dual Targeted Nanoparticles Encapsulating Cantharidin for Treatment of Hepatocellular Carcinoma and Lymphatic Metastasis
    Wenwen Jiao et al, 2024, ACS Applied Nano Materials CrossRef
  2. Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging
    Stefanie J. Hectors et al, 2017, Scientific Reports CrossRef
  3. Identification of miRNA-mRNA associations in hepatocellular carcinoma using hierarchical integrative model
    Rency S. Varghese et al, 2020, BMC Medical Genomics CrossRef
  4. LC‐MS/MS‐based serum proteomics for identification of candidate biomarkers for hepatocellular carcinoma
    Tsung‐Heng Tsai et al, 2015, PROTEOMICS CrossRef
  5. The prognostic influence of lymphatic endothelium–specific hyaluronan receptor 1 in cancer: A systematic review
    Sini Karinen et al, 2022, Cancer Science CrossRef
  6. Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
    Paula Fernández-Palanca et al, 2023, Clinical and Molecular Hepatology CrossRef
  7. Update June 2014
    Francine Blei, 2014, Lymphatic Research and Biology CrossRef
  8. Hyaluronic acid as a tumor progression agent and a potential chemotherapeutic biomolecule against cancer: A review on its dual role
    Simran Gagneja et al, 2024, International Journal of Biological Macromolecules CrossRef
  9. Multifaceted roles of lymphatic and blood endothelial cells in the tumor microenvironment of hepatocellular carcinoma: A comprehensive review
    Jing-Jing Li et al, 2024, World Journal of Hepatology CrossRef
  10. The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis
    Masatake Tanaka et al, 2016, Cellular and Molecular Gastroenterology and Hepatology CrossRef
  11. A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma
    Hui Hu et al, 2022, Cells CrossRef
  12. hsa_circ_0129047 Upregulates LYVE1 to Inhibit Hepatocellular Carcinoma Progression by Sponging miR-492
    Zhenzhen Feng et al, 2023, Disease Markers CrossRef